Aug 20, 2020   SOURCE: BusinessWire

An Active Pharmaceutical Ingredients Market Client Gains Significant Market Share | Infiniti’s Success with Market Landscape Analysis

Infiniti’s research experts have projected the active pharmaceutical ingredients market to achieve profitable growth through 2022. However, increasing penetration of counterfeit drugs, more difficult and strenuous regulation processes, and rising competition are challenges that continue to plague the industry. These challenges cause delays in operations, a decline in sales rates, high operational costs, and significant losses. This has led to a need for innovative ideas and complex APIs that find use in novel formulations. Additionally, active pharmaceutical ingredients market players must improve efficiency and quality and balance costs. Infiniti’s market landscape analysis solutions enables companies to analyze the market, identify the challenges, and develop strategic initiatives to overcome them. This helps improve operational costs, enhance savings, and reduce risk. To leverage our expertise in the active pharmaceutical ingredients market and improve efficiency, request a free proposal.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200820005378/en/

Market Landscape Analysis for an Active Pharmaceutical Ingredients Market Client (Graphic: Business Wire)

Market Landscape Analysis for an Active Pharmaceutical Ingredients Market Client (Graphic: Business Wire)

“According to a new study by Infiniti Research, the active pharmaceutical ingredients market is projected to achieve profitable growth through 2022, owing to the growing importance of generics and increasing uptake of biopharmaceuticals. Also, the rising market demand for anti-infectives, diabetes, and pain killer drugs are projected to contribute to the active pharmaceutical ingredients market growth,” says an active pharmaceutical ingredients market expert at Infiniti Research.

Business Challenge:

The client is an active pharmaceutical ingredients manufacturer based out of France. The company witnessed a decline in its sales rate for two consecutive years, due to two major factors. First, the increase of high safety standards and scrutiny by the FDA caused the rate of new chemical entities to decline rapidly. Secondly, the R&D and certification processes became longer, and the client faced difficulties in getting approval for their new drugs. The active pharmaceutical ingredients market client sought to overcome these challenges by leveraging Infiniti’s expertise in offering market landscape analysis. They also wanted to thoroughly analyze the market landscape, identify investment opportunities, and recover from the lost sales.

Our Approach:

Infiniti’s research experts proposed a market landscape analysis solution to help the active pharmaceutical market player. The solution included the following:

  • A detailed secondary research that involved gathering insights from industry reports, discussion boards, news, publications, and other open sources
  • Primary research that involved conducting 120-130 semi-structured telephone interviews with research specialists, analysts, and other market stakeholders
  • Mapping and prioritization of technologies and deducing the optimal set of opportunities that best fit the client’s strategic imperative
  • A detailed addressable market analysis of each best-fit opportunity in terms of market attractiveness, competitive factors, and end-user preferences

Gain a comprehensive understanding of our market landscape analysis solutions by reading the complete article here.

Business Outcome:

By leveraging Infiniti’s market landscape analysis, the active pharmaceutical ingredients market player was enabled to analyze the industry, forecast its growth, and gather insights on the regulatory and competitive environment. The client was also able to partner with the best technology provides, identify challenges associated with drug approvals, and select appropriate packaging materials for their drugs. Additionally, the client adopted strategic initiatives to address challenges caused by rapidly changing prices and regulatory issues. Infiniti’s market landscape analysis engagement assisted the active pharmaceutical ingredients market player to reduce operational costs, gain 13% share in its new drug category within one year, and generate $4.8 million in savings.

To further understand the strategic initiatives required to overcome challenges in the active pharmaceutical ingredient market, speak to our industry research experts.

About Infiniti Research

Established in 2003, Infiniti Research is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to help analyze competitive activity, see beyond market disruptions, and develop intelligent business strategies. To know more, visit: https://www.infinitiresearch.com/about-us